Literature DB >> 33466152

Paraneoplastic pemphigus associated with small lymphocytic lymphoma: A case report.

Dafen Wang1, Zhilu Chen.   

Abstract

INTRODUCTION: Paraneoplastic pemphigus (PNP) is a life-threatening autoimmune blistering disease associated with underlying neoplasms. Currently, this disease is very difficult to treat. PATIENT CONCERNS: We reported a rare case of paraneoplastic pemphigus associated with small lymphocytic lymphoma responsive to desmoglein 3 (Dsg3) and bullous pemphigoid (BP) antigen 180. DIAGNOSES: The initial diagnosis was hypothesized to be Stevens-Johnson syndrome based on the severe mucosal erosion and polymorphous skin lesions. However, the histopathological examination of the skin biopsy and immunology revealed PNP.
INTERVENTIONS: Anti-tumor therapy, immunosuppression and anti-infective therapy were administered. OUTCOMES: After a series of treatments, the skin lesions had been alleviated remarkably. Enzyme-linked immunoassays indices for Dsg3 and bullous pemphigoid antigen 180 decreased (Dsg3, 32; bullous pemphigoid antigen 180, 70.44). Unfortunately, 2 months later, the patient suffered respiratory failure due to the lung impairment of small lymphocytic lymphoma and infection. Eventually, the patient chose to be discharged from the hospital and lost the opportunity for follow-up treatment as he could not afford the expensive treatment costs. LESSONS: It is highly susceptible to misdiagnosis due to polymorphous skin lesions. In this case, it was also initially misdiagnosed as Stevens-Johnson syndrome. Therefore, we should pay great attention to differential diagnosis. When refractory stomatitis and mucosal erosions occur, the possibility of PNP should be considered first. At the same time, pathology, immunology and other related tests as well as the examination of primary tumors should be carried out as soon as possible.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33466152      PMCID: PMC7808545          DOI: 10.1097/MD.0000000000024039

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  10 in total

1.  Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus.

Authors:  A M Poot; J Siland; M F Jonkman; H H Pas; G F H Diercks
Journal:  Br J Dermatol       Date:  2016-01-27       Impact factor: 9.302

2.  Paraneoplastic pemphigus as a presentation of acute myeloid leukemia: Early diagnosis and remission.

Authors:  Salahuddin Siddiqui; Mohammad Bilal; Zachary Otaibi; Farshaad Bilimoria; Nihar Patel; James Rossetti
Journal:  Hematol Oncol Stem Cell Ther       Date:  2016-06-23

3.  Prognostic factors of paraneoplastic pemphigus.

Authors:  Sandy Leger; Damien Picard; Saskia Ingen-Housz-Oro; Jean-Philippe Arnault; François Aubin; Francis Carsuzaa; Gilles Chaumentin; Jacqueline Chevrant-Breton; Olivier Chosidow; Béatrice Crickx; Michel D'incan; Michel Dandurand; Stéphane Debarbieux; Emmanuel Delaporte; Olivier Dereure; Marie-Sylvie Doutre; Gérard Guillet; Denis Jullien; Ingrid Kupfer; Jean-Philippe Lacour; Fabienne Leonard; Catherine Lok; Laurent Machet; Ludovic Martin; Carle Paul; Jean-Michel Pignon; Caroline Robert; Luc Thomas; Pierre-Jean Weiller; Vincent Ferranti; Danièle Gilbert; Philippe Courville; Estelle Houivet; Jacques Benichou; Pascal Joly
Journal:  Arch Dermatol       Date:  2012-10

Review 4.  Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.

Authors:  A Tirado-Sánchez; A Bonifaz
Journal:  Actas Dermosifiliogr       Date:  2017-08-08

5.  Immunological and statistical studies of anti-BP180 antibodies in paraneoplastic pemphigus.

Authors:  Atsunari Tsuchisaka; Hideo Kawano; Atsushi Yasukochi; Kwesi Teye; Norito Ishii; Hiroshi Koga; Ryosuke Sogame; Ayaka Ohzono; Rafal P Krol; Tamihiro Kawakami; Minao Furumura; Chika Ohata; Xiaoguang Li; Takashi Hashimoto
Journal:  J Invest Dermatol       Date:  2014-03-31       Impact factor: 8.551

6.  Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus.

Authors:  Jennifer Gall Powell; Raminder K Grover; Richard W Plunkett; Kristina Seiffert-Sinha; Animesh A Sinha
Journal:  J Drugs Dermatol       Date:  2015-10       Impact factor: 2.114

7.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

8.  Successful use of Bruton's kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia.

Authors:  Andrew Lee; Suneet Sandhu; Louise Imlay-Gillespie; Stephen Mulligan; Stephen Shumack
Journal:  Australas J Dermatol       Date:  2017-03-13       Impact factor: 2.875

Review 9.  Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.

Authors:  Jing Wang; Xuejun Zhu; Ruoyu Li; Ping Tu; Rengui Wang; Lanbo Zhang; Ting Li; Xixue Chen; Aiping Wang; Shuxia Yang; Yan Wu; Haizhen Yang; Suzhen Ji
Journal:  Arch Dermatol       Date:  2005-10

Review 10.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.